Connection

Stephen Ethier to Humans

This is a "connection" page, showing publications Stephen Ethier has written about Humans.
Connection Strength

0.718
  1. Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer. PLoS One. 2019; 14(11):e0224420.
    View in: PubMed
    Score: 0.026
  2. Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer. BMC Cancer. 2019 May 23; 19(1):491.
    View in: PubMed
    Score: 0.025
  3. Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3. Breast Cancer Res Treat. 2017 Jul; 164(2):349-358.
    View in: PubMed
    Score: 0.022
  4. Functional oncogene signatures guide rationally designed combination therapies to synergistically induce breast cancer cell death. Oncotarget. 2016 Jun 14; 7(24):36138-36153.
    View in: PubMed
    Score: 0.020
  5. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERa in SUM-44 breast cancer cells and is associated with ERa over-expression in breast cancer. Mol Oncol. 2016 06; 10(6):850-65.
    View in: PubMed
    Score: 0.020
  6. Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes. Exp Cell Res. 2015 Mar 15; 332(2):223-35.
    View in: PubMed
    Score: 0.019
  7. Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer. Mol Oncol. 2015 Feb; 9(2):527-43.
    View in: PubMed
    Score: 0.018
  8. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia. 2014 Aug; 16(8):644-55.
    View in: PubMed
    Score: 0.018
  9. Knock-down of amphiregulin inhibits cellular invasion in inflammatory breast cancer. J Cell Physiol. 2011 Oct; 226(10):2691-701.
    View in: PubMed
    Score: 0.015
  10. Oncogene activation induces metabolic transformation resulting in insulin-independence in human breast cancer cells. PLoS One. 2011 Mar 17; 6(3):e17959.
    View in: PubMed
    Score: 0.014
  11. Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer. J Thorac Oncol. 2011 Mar; 6(3):627-30.
    View in: PubMed
    Score: 0.014
  12. Transforming properties of 8p11-12 amplified genes in human breast cancer. Cancer Res. 2010 Nov 01; 70(21):8487-97.
    View in: PubMed
    Score: 0.014
  13. HER-2 signaling, acquisition of growth factor independence, and regulation of biological networks associated with cell transformation. Cancer Res. 2010 Oct 15; 70(20):7862-73.
    View in: PubMed
    Score: 0.014
  14. Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers. Int J Cancer. 2009 Oct 01; 125(7):1613-21.
    View in: PubMed
    Score: 0.013
  15. Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop. Cell Signal. 2009 Feb; 21(2):212-9.
    View in: PubMed
    Score: 0.012
  16. Amphiregulin as a novel target for breast cancer therapy. J Mammary Gland Biol Neoplasia. 2008 Jun; 13(2):171-9.
    View in: PubMed
    Score: 0.012
  17. Transforming properties of TC-1 in human breast cancer: interaction with FGFR2 and beta-catenin signaling pathways. Int J Cancer. 2007 Sep 15; 121(6):1265-73.
    View in: PubMed
    Score: 0.011
  18. Activation of a nuclear factor kappaB/interleukin-1 positive feedback loop by amphiregulin in human breast cancer cells. Mol Cancer Res. 2007 Aug; 5(8):847-61.
    View in: PubMed
    Score: 0.011
  19. Differential signal transduction of alternatively spliced FGFR2 variants expressed in human mammary epithelial cells. J Cell Physiol. 2007 Mar; 210(3):720-31.
    View in: PubMed
    Score: 0.011
  20. Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res. 2006 Dec 15; 66(24):11632-43.
    View in: PubMed
    Score: 0.011
  21. Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells. J Biol Chem. 2006 Dec 08; 281(49):37728-37.
    View in: PubMed
    Score: 0.010
  22. Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon. Oncogene. 2007 Mar 29; 26(14):2104-14.
    View in: PubMed
    Score: 0.010
  23. Cooperative interactions of HER-2 and HPV-16 oncoproteins in the malignant transformation of human mammary epithelial cells. Neoplasia. 2005 Aug; 7(8):788-98.
    View in: PubMed
    Score: 0.010
  24. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells. Oncogene. 2005 Apr 28; 24(19):3177-86.
    View in: PubMed
    Score: 0.009
  25. Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines. Cancer Genet Cytogenet. 2004 Nov; 155(1):57-62.
    View in: PubMed
    Score: 0.009
  26. Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells. Mol Cancer Res. 2004 Nov; 2(11):643-52.
    View in: PubMed
    Score: 0.009
  27. Chromosomal instability and lack of cyclin E regulation in hCdc4 mutant human breast cancer cells. Breast Cancer Res. 2004; 6(5):R531-9.
    View in: PubMed
    Score: 0.009
  28. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines. Cancer Res. 2004 Jan 01; 64(1):40-7.
    View in: PubMed
    Score: 0.009
  29. The role of phosphatidylinositol 3'-kinase and its downstream signals in erbB-2-mediated transformation. Mol Cancer Res. 2003 May; 1(7):551-60.
    View in: PubMed
    Score: 0.008
  30. Identifying and validating causal genetic alterations in human breast cancer. Breast Cancer Res Treat. 2003 Apr; 78(3):285-7.
    View in: PubMed
    Score: 0.008
  31. p38MAPK induces cell surface alpha4 integrin downregulation to facilitate erbB-2-mediated invasion. Neoplasia. 2003 Mar-Apr; 5(2):128-34.
    View in: PubMed
    Score: 0.008
  32. Lack of functional pRb results in attenuated recovery of mRNA synthesis and increased apoptosis following UV radiation in human breast cancer cells. Oncogene. 2002 Jul 04; 21(29):4481-9.
    View in: PubMed
    Score: 0.008
  33. Signal transduction pathways: the molecular basis for targeted therapies. Semin Radiat Oncol. 2002 Jul; 12(3 Suppl 2):3-10.
    View in: PubMed
    Score: 0.008
  34. Epidermal growth factor receptor signaling and response of cancer cells to ionizing radiation. J Natl Cancer Inst. 2001 Jun 20; 93(12):890-1.
    View in: PubMed
    Score: 0.007
  35. Radiosensitization of human breast cancer cells by a novel ErbB family receptor tyrosine kinase inhibitor. Int J Radiat Oncol Biol Phys. 2000 Dec 01; 48(5):1519-28.
    View in: PubMed
    Score: 0.007
  36. Lack of RB protein correlates with increased sensitivity to UV-radiation-induced apoptosis in human breast cancer cells. Radiat Res. 2000 Nov; 154(5):590-9.
    View in: PubMed
    Score: 0.007
  37. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells. J Cell Physiol. 2000 Jun; 183(3):301-13.
    View in: PubMed
    Score: 0.007
  38. Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE. Breast Cancer Res. 2000; 2(4):311-20.
    View in: PubMed
    Score: 0.007
  39. ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity on human mammary epithelial cells. Br J Cancer. 2000 Feb; 82(3):666-74.
    View in: PubMed
    Score: 0.007
  40. Molecular cytogenetic analysis of 11 new breast cancer cell lines. Br J Cancer. 1999 Dec; 81(8):1328-34.
    View in: PubMed
    Score: 0.007
  41. erbB-2 overexpression in human mammary epithelial cells confers growth factor independence. Endocrinology. 1999 Aug; 140(8):3615-22.
    View in: PubMed
    Score: 0.006
  42. Constitutive activation of pp125fak in newly isolated human breast cancer cell lines. Breast Cancer Res Treat. 1999 Mar; 54(2):173-82.
    View in: PubMed
    Score: 0.006
  43. ICOSL-augmented adenoviral-based vaccination induces a bipolar Th17/Th1 T cell response against unglycosylated MUC1 antigen. Vaccine. 2018 10 08; 36(42):6262-6269.
    View in: PubMed
    Score: 0.006
  44. MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer. Cancer Res. 2017 12 01; 77(23):6641-6650.
    View in: PubMed
    Score: 0.006
  45. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res. 1997 Mar 01; 57(5):978-87.
    View in: PubMed
    Score: 0.005
  46. Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers. Nat Commun. 2016 10 11; 7:13050.
    View in: PubMed
    Score: 0.005
  47. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification. Cell Growth Differ. 1996 May; 7(5):551-61.
    View in: PubMed
    Score: 0.005
  48. MYC Is a Crucial Mediator of TGF?-Induced Invasion in Basal Breast Cancer. Cancer Res. 2016 06 15; 76(12):3520-30.
    View in: PubMed
    Score: 0.005
  49. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2. Mol Carcinog. 1996 Mar; 15(3):227-38.
    View in: PubMed
    Score: 0.005
  50. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. Cancer Res. 1996 Feb 15; 56(4):899-907.
    View in: PubMed
    Score: 0.005
  51. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha. Mol Carcinog. 1996 Feb; 15(2):134-43.
    View in: PubMed
    Score: 0.005
  52. Human breast cancer cell lines as models of growth regulation and disease progression. J Mammary Gland Biol Neoplasia. 1996 Jan; 1(1):111-21.
    View in: PubMed
    Score: 0.005
  53. Overexpression of GAB2 in ovarian cancer cells promotes tumor growth and angiogenesis by upregulating chemokine expression. Oncogene. 2016 08 04; 35(31):4036-47.
    View in: PubMed
    Score: 0.005
  54. The culture of cell culture practices and authentication--Results from a 2015 Survey. Biotechniques. 2015 Oct; 59(4):189-90, 192.
    View in: PubMed
    Score: 0.005
  55. Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer. Breast Cancer Res. 2015 Sep 22; 17:130.
    View in: PubMed
    Score: 0.005
  56. Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst. 1995 Jul 05; 87(13):964-73.
    View in: PubMed
    Score: 0.005
  57. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells. J Cell Physiol. 1995 Jun; 163(3):589-96.
    View in: PubMed
    Score: 0.005
  58. Reproducibility: changing the policies and culture of cell line authentication. Nat Methods. 2015 Jun; 12(6):493-7.
    View in: PubMed
    Score: 0.005
  59. Perspectives on Epidermal Growth Factor Receptor Regulation in Triple-Negative Breast Cancer: Ligand-Mediated Mechanisms of Receptor Regulation and Potential for Clinical Targeting. Adv Cancer Res. 2015; 127:253-81.
    View in: PubMed
    Score: 0.005
  60. Carotenoids induce morphological changes in human mammary epithelial cell cultures. Nutr Cancer. 1995; 23(3):319-33.
    View in: PubMed
    Score: 0.005
  61. SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression. Mol Cancer Ther. 2014 Nov; 13(11):2713-26.
    View in: PubMed
    Score: 0.005
  62. Finite proliferative lifespan in vitro of a human breast cancer cell strain isolated from a metastatic lymph node. Breast Cancer Res Treat. 1993 Dec; 28(3):267-76.
    View in: PubMed
    Score: 0.004
  63. Insulin like growth factor-I independence in rat mammary carcinoma cells: a dominant phenotype in somatic cell hybrid experiments. Cancer Lett. 1993 Nov 01; 74(3):189-95.
    View in: PubMed
    Score: 0.004
  64. Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell. 2013 Oct 14; 24(4):450-65.
    View in: PubMed
    Score: 0.004
  65. Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes. Mol Oncol. 2012 Oct; 6(5):494-506.
    View in: PubMed
    Score: 0.004
  66. ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways. BMC Cancer. 2012 Jun 08; 12:225.
    View in: PubMed
    Score: 0.004
  67. Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology. 1992 Jun; 183(3):643-7.
    View in: PubMed
    Score: 0.004
  68. Induction of proapoptotic antibodies to triple-negative breast cancer by vaccination with TRAIL death receptor DR5 DNA. Int J Cancer. 2012 Dec 01; 131(11):2562-72.
    View in: PubMed
    Score: 0.004
  69. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res. 2011 Oct 01; 71(19):6195-207.
    View in: PubMed
    Score: 0.004
  70. Identification and functional analysis of 9p24 amplified genes in human breast cancer. Oncogene. 2012 Jan 19; 31(3):333-41.
    View in: PubMed
    Score: 0.004
  71. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res. 2011 Feb 15; 71(4):1292-301.
    View in: PubMed
    Score: 0.004
  72. Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo. Cancer Res. 2010 May 15; 70(10):3996-4004.
    View in: PubMed
    Score: 0.003
  73. Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Oncogene. 2009 Dec 17; 28(50):4491-500.
    View in: PubMed
    Score: 0.003
  74. Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Res Treat. 2010 May; 121(1):53-64.
    View in: PubMed
    Score: 0.003
  75. Activation of Src by protein tyrosine phosphatase 1B Is required for ErbB2 transformation of human breast epithelial cells. Cancer Res. 2009 Jun 01; 69(11):4582-8.
    View in: PubMed
    Score: 0.003
  76. Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study. Cancer Res. 2008 Dec 15; 68(24):10045-50.
    View in: PubMed
    Score: 0.003
  77. ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer. Cancer Res. 2008 Nov 01; 68(21):8908-17.
    View in: PubMed
    Score: 0.003
  78. Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells. Cancer Res. 2008 May 01; 68(9):3314-22.
    View in: PubMed
    Score: 0.003
  79. Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines. Breast Cancer Res Treat. 2009 Jan; 113(2):285-91.
    View in: PubMed
    Score: 0.003
  80. Comprehensive analysis of oncogenic effects of PIK3CA mutations in human mammary epithelial cells. Breast Cancer Res Treat. 2008 Nov; 112(2):217-27.
    View in: PubMed
    Score: 0.003
  81. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet. 2008 Jan; 40(1):102-7.
    View in: PubMed
    Score: 0.003
  82. p38MAPK-activated AKT in HER-2 overexpressing human breast cancer cells acts as an EGF-independent survival signal. J Surg Res. 2007 Sep; 142(1):162-9.
    View in: PubMed
    Score: 0.003
  83. LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer. Cancer Res. 2007 May 01; 67(9):4123-9.
    View in: PubMed
    Score: 0.003
  84. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006 Dec; 10(6):515-27.
    View in: PubMed
    Score: 0.003
  85. Serum-free culture conditions for the growth of normal rat mammary epithelial cells in primary culture. In Vitro Cell Dev Biol. 1986 Aug; 22(8):485-90.
    View in: PubMed
    Score: 0.003
  86. New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK. Breast Cancer Res Treat. 2006 Nov; 100(2):237-8.
    View in: PubMed
    Score: 0.003
  87. Differential phosphoprotein mapping in cancer cells using protein microarrays produced from 2-D liquid fractionation. Anal Chem. 2006 Feb 01; 78(3):702-10.
    View in: PubMed
    Score: 0.002
  88. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res. 2006 Jan 01; 66(1):41-5.
    View in: PubMed
    Score: 0.002
  89. Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol Cancer Res. 2005 Dec; 3(12):655-67.
    View in: PubMed
    Score: 0.002
  90. Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells. Cancer Res. 2004 Dec 01; 64(23):8674-81.
    View in: PubMed
    Score: 0.002
  91. Cleavage of beta-catenin by calpain in prostate and mammary tumor cells. Cancer Res. 2004 Oct 15; 64(20):7237-40.
    View in: PubMed
    Score: 0.002
  92. Stat3 modulates heat shock 27kDa protein expression in breast epithelial cells. Biochem Biophys Res Commun. 2004 Jan 30; 314(1):143-50.
    View in: PubMed
    Score: 0.002
  93. Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivo. Clin Cancer Res. 2004 Jan 15; 10(2):691-700.
    View in: PubMed
    Score: 0.002
  94. Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res. 2003 Jan 01; 63(1):132-9.
    View in: PubMed
    Score: 0.002
  95. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res. 2001 Jul 01; 61(13):5168-78.
    View in: PubMed
    Score: 0.002
  96. Differential screening and mass mapping of proteins from premalignant and cancer cell lines using nonporous reversed-phase HPLC coupled with mass spectrometric analysis. Anal Chem. 2001 Mar 15; 73(6):1219-27.
    View in: PubMed
    Score: 0.002
  97. Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells. Genes Chromosomes Cancer. 2000 Dec; 29(4):356-62.
    View in: PubMed
    Score: 0.002
  98. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res. 2000 Aug 15; 60(16):4519-25.
    View in: PubMed
    Score: 0.002
  99. A bcl-xS adenovirus selectively induces apoptosis in transformed cells compared to normal mammary cells. Neoplasia. 2000 May-Jun; 2(3):251-60.
    View in: PubMed
    Score: 0.002
  100. SUM-159PT cells: a novel estrogen independent human breast cancer model system. Breast Cancer Res Treat. 1999 Dec; 58(3):193-204.
    View in: PubMed
    Score: 0.002
  101. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res. 1999 Sep; 5(9):2511-9.
    View in: PubMed
    Score: 0.002
  102. HPV16-E7 expression causes fluorodeoxyuridine-mediated radiosensitization in SW620 human colon cancer cells. Neoplasia. 1999 Jun; 1(2):177-82.
    View in: PubMed
    Score: 0.002
  103. Benzo[a]pyrene- and TCDD-induced alterations in tyrosine phosphorylation and insulin-like growth factor signaling pathways in the MCF-10A human mammary epithelial cell line. Carcinogenesis. 1998 Jul; 19(7):1291-7.
    View in: PubMed
    Score: 0.001
  104. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ. 1997 Dec; 8(12):1267-76.
    View in: PubMed
    Score: 0.001
  105. CaN19 expression in benign and malignant hyperplasias of the skin and oral mucosa: evidence for a role in regenerative differentiation. Cancer Res. 1997 Jul 15; 57(14):3055-62.
    View in: PubMed
    Score: 0.001
  106. Carcinogenic polycyclic aromatic hydrocarbons increase intracellular Ca2+ and cell proliferation in primary human mammary epithelial cells. Carcinogenesis. 1997 Jun; 18(6):1177-82.
    View in: PubMed
    Score: 0.001
  107. BRCA1 protein level is not affected by peptide growth factors in MCF10A cell line. Oncogene. 1996 Dec 05; 13(11):2487-91.
    View in: PubMed
    Score: 0.001
  108. Biological disposition and imaging of a radioiodinated alkylphosphocholine in two rodent models of breast cancer. J Nucl Med. 1996 Sep; 37(9):1540-5.
    View in: PubMed
    Score: 0.001
  109. Fluorine-18-fluorodeoxyglucose-guided breast cancer surgery with a positron-sensitive probe: validation in preclinical studies. J Nucl Med. 1995 Oct; 36(10):1869-74.
    View in: PubMed
    Score: 0.001
  110. Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas. Br J Cancer. 1995 Jul; 72(1):56-64.
    View in: PubMed
    Score: 0.001
  111. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol. 1994 Mar; 12(3):475-82.
    View in: PubMed
    Score: 0.001
  112. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res. 1993 Feb 01; 53(3):627-35.
    View in: PubMed
    Score: 0.001
  113. The influence of growth factors on the proliferative potential of normal and primary breast cancer-derived human breast epithelial cells. Breast Cancer Res Treat. 1991 Jan-Feb; 17(3):221-30.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.